Lupus Nephritis: Review of the Literature

被引:20
作者
Zubair, Adeel [1 ]
Frieri, Marianne [2 ]
机构
[1] Mayo Clin & Mayo Grad Sch Med, Rochester, MN 55905 USA
[2] Nassau Univ, Med Ctr, Dept Med & Pediat, E Meadow, NY 11554 USA
关键词
Systemic lupus erythematosus; Lupus nephritis; Vascular endothelial growth factor; TLR9; Diagnosis; Treatment; Prognosis; PROTEIN-LOSING ENTEROPATHY; ENDOTHELIAL GROWTH-FACTOR; MYCOPHENOLATE-MOFETIL; MAINTENANCE THERAPY; INDUCTION THERAPY; ERYTHEMATOSUS; CYCLOPHOSPHAMIDE; MANAGEMENT; CLASSIFICATION; EFFICACY;
D O I
10.1007/s11882-013-0394-4
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Physicians in practice should be knowledgeable regarding several aspects of autoimmune disorders, especially systemic lupus erythematosus (SLE) and lupus nephritis. These disorders can present to the clinician's clinic and private office regardless of their speciality. This review will discuss various aspects of SLE, its mechanisms of disease, role of accelerated atherosclerosis, proinflammatory cytokines, and therapeutic approaches. The role of vascular endothelial growth factor in which and plasma levels have been associated with disease activity, classification of severity, and diagnosis of lupus nephritis is addressed. Current treatment options, prognosis, and future therapeutic approaches and common side effects are also discussed.
引用
收藏
页码:580 / 586
页数:7
相关论文
共 72 条
[1]  
Akkina S, 2012, ANN ALLERG ASTHMA IM, V109, P302
[2]  
Akkina SBK, 2012, ANN ALLERG ASTHMA IM, V109
[3]   Metastatic Melanoma to the Heart [J].
Allen, Brian C. ;
Mohammed, Tan Lucien ;
Tan, Carmela D. ;
Miller, Dylan V. ;
Williamson, Eric E. ;
Kirsch, Jacobo S. .
CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2012, 41 (05) :159-164
[4]   Treatment of Proliferative and Membranous Lupus Nephritis: Review of Key Clinical Trials [J].
Alshayeb, Hala ;
Wall, Barry M. ;
Gosmanova, Elvira O. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 343 (01) :86-90
[5]   An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases [J].
Appel, Alice S. ;
Appel, Gerald B. .
NATURE CLINICAL PRACTICE NEPHROLOGY, 2009, 5 (03) :132-142
[6]   New and future therapies for lupus nephritis [J].
Appel, Gerald B. .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2012, 79 (02) :134-140
[7]   Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis [J].
Aragon, E. ;
Chan, Y. H. ;
Ng, K. H. ;
Lau, Y. W. ;
Tan, P. H. ;
Yap, H. K. .
LUPUS, 2010, 19 (08) :965-973
[8]   Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis [J].
Arends, Suzanne ;
Grootscholten, Cecile ;
Derksen, Ronald H. W. M. ;
Berger, Stefan P. ;
de Sevaux, Ruud G. L. ;
Voskuyl, Alexandre E. ;
Bijl, Marc ;
Berden, Jo H. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (06) :966-973
[9]   Major lupus organ involvement: severe lupus nephritis [J].
Avihingsanon, Y. ;
Hirankarn, N. .
LUPUS, 2010, 19 (12) :1391-1398
[10]   Systemic lupus erythematosus complicated with protein-losing enteropathy: A case report and review of the published works [J].
Awazawa, Ryoko ;
Yamamoto, Yu-ichi ;
Mine, Yoshiko ;
Nakamura, Ikumi ;
Kishimoto, Kazuto ;
Kinjyo, Fukunori ;
Hagiwara, Keisuke ;
Fujita, Jiro ;
Uezato, Hiroshi ;
Takahashi, Kenzo .
JOURNAL OF DERMATOLOGY, 2012, 39 (05) :454-461